Current Trends and Innovative Approaches in Cancer Immunotherapy
- PMID: 39044047
- DOI: 10.1208/s12249-024-02883-x
Current Trends and Innovative Approaches in Cancer Immunotherapy
Abstract
Immunotherapy is one of the most promising therapeutic approaches in the field of cancer treatment. As a tumor progresses, tumor cells employ an array of immune-regulatory mechanisms to suppress immune responses within the tumor microenvironment. Using our understanding of these mechanisms, cancer immunotherapy has been developed to enhance the immune system's effectiveness in treating cancer. Numerous cancer immunotherapies are currently in clinical use, yet many others are either in different stages of development or undergoing clinical studies. In this paper, we briefly discuss the features and current status of cancer immunotherapies. This includes the application of monoclonal antibodies, immune checkpoint inhibitors, adoptive cell therapy, cytokine therapy, cancer vaccines, and gene therapy, all of which have gained significant recognition in clinical practice. Additionally, we discuss limitations that may hinder successful clinical utilization and promising strategies, such as combining immunotherapy with nanotechnology.
Keywords: cancer immunotherapy; combination therapy; immunomodulation.
© 2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
Similar articles
-
Next-generation cancer vaccines and emerging immunotherapy combinations.Trends Cancer. 2024 Aug;10(8):749-769. doi: 10.1016/j.trecan.2024.06.003. Epub 2024 Jul 23. Trends Cancer. 2024. PMID: 39048489 Review.
-
Immunomodulatory nanoparticles activate cytotoxic T cells for enhancement of the effect of cancer immunotherapy.Nanoscale. 2024 Oct 3;16(38):17699-17722. doi: 10.1039/d4nr01780c. Nanoscale. 2024. PMID: 39257225 Review.
-
Extracellular Vesicles in Oncology: from Immune Suppression to Immunotherapy.AAPS J. 2021 Feb 14;23(2):30. doi: 10.1208/s12248-021-00554-4. AAPS J. 2021. PMID: 33586060 Free PMC article. Review.
-
CD4+ T cells in antitumor immunity.Trends Cancer. 2024 Oct;10(10):969-985. doi: 10.1016/j.trecan.2024.07.009. Epub 2024 Sep 5. Trends Cancer. 2024. PMID: 39242276 Review.
-
Emerging Immunotherapies for Cancer and Their Potential for Application in Pediatric Oncology.Crit Rev Oncog. 2015;20(3-4):315-27. doi: 10.1615/critrevoncog.2015013861. Crit Rev Oncog. 2015. PMID: 26349422 Review.
References
-
- Rui R, Zhou L, He S. Cancer immunotherapies: advances and bottlenecks. Front Immunol. 2023;14:1212476. https://doi.org/10.3389/fimmu.2023.1212476 . - DOI - PubMed - PMC
-
- Debela DT, Muzazu SG, Heraro KD, Ndalama MT, Mesele BW, Haile DC, et al. New approaches and procedures for cancer treatment: Current perspectives. SAGE Open Med. 2021;9. https://doi.org/10.1177/20503121211034366 .
-
- Dillman RO. Cancer immunotherapy. Cancer Biother Radiopharm. 2011;26(1):1–64. https://doi.org/10.1089/cbr.2010.0902 . - DOI - PubMed
-
- Sambi M, Bagheri L, Szewczuk MR. Current challenges in cancer immunotherapy: multimodal approaches to improve efficacy and patient response rates. J Oncol. 2019;2019:4508794. https://doi.org/10.1155/2019/4508794 . - DOI - PubMed - PMC
-
- Zhang H, Chen J. Current status and future directions of cancer immunotherapy. J Cancer. 2018;9(10):1773–81. https://doi.org/10.7150/jca.24577 . - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials